1. Home
  2. CXW vs ADMA Comparison

CXW vs ADMA Comparison

Compare CXW & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CoreCivic Inc.

CXW

CoreCivic Inc.

HOLD

Current Price

$20.45

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.84

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXW
ADMA
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
CXW
ADMA
Price
$20.45
$10.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$32.00
$25.67
AVG Volume (30 Days)
689.1K
4.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.19
N/A
EPS
1.08
0.60
Revenue
$2,211,182,000.00
$42,219,783.00
Revenue This Year
$17.13
$27.46
Revenue Next Year
$5.64
$22.11
P/E Ratio
$18.97
$18.18
Revenue Growth
12.72
43.85
52 Week Low
$15.74
$7.21
52 Week High
$23.54
$24.17

Technical Indicators

Market Signals
Indicator
CXW
ADMA
Relative Strength Index (RSI) 57.07 44.68
Support Level $19.27 $7.21
Resistance Level $21.01 $16.48
Average True Range (ATR) 0.52 0.47
MACD -0.03 0.29
Stochastic Oscillator 70.24 68.43

Price Performance

Historical Comparison
CXW
ADMA

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: